|
|
Exchange: |
N/A |
Security
Type: |
N/A |
Shares
Out: |
18,500,000 |
Market
Cap: |
N/A |
Last
Volume: |
0 |
Avg
Vol: |
0 |
52
Week Range: |
$1.15 - $1.15 |
|
Level
I Sector: |
N/A |
Level
II Sector: |
N/A |
Level
III Sector: |
N/A |
|
Member Indexes:
|
Rankings:
|
Insider 3 Months : - |
Insider 6 Months : - |
Insider 3/6 Months : - |
|
Guru Rank Number : - |
Guru Rank Value : - |
Guru Occurances : - |
|
|
|
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
3m +/-:
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
Actions:
|
|
|
B |
Buy |
S |
Sell |
OE |
Option
Exercised |
A |
Acquired |
D |
Disposed |
AB |
Automatic
Buy |
AS |
Automatic
Sell |
IO |
Initial
Ownership |
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
|
|
Summary (Direct Transactions Only) |
3 Months |
6 Months |
12 Months |
24 Months |
Total Shares Bought |
0 |
0 |
302,571 |
452,571 |
Total Buy Value |
$0 |
$0 |
$79,191 |
$278,721 |
Total People Bought |
0 |
0 |
2 |
4 |
Total Buy Transactions |
0 |
0 |
4 |
6 |
Total Shares Sold |
0 |
0 |
0 |
36,895 |
Total Sell Value |
$0 |
$0 |
$0 |
$86,142 |
Total People Sold |
0 |
0 |
0 |
4 |
Total Sell Transactions |
0 |
0 |
0 |
4 |
End Date |
2024-02-04 |
2023-11-03 |
2023-05-05 |
2022-05-05 |
|
Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
Rudy Jeffrey J |
VP, Clinical Operations |
|
2015-01-09 |
4 |
AS |
$18.51 |
$185,100 |
D/D |
(10,000) |
1,024 |
|
- |
|
Rudy Jeffrey J |
VP, Clinical Operations |
|
2015-01-09 |
4 |
OE |
$1.12 |
$11,200 |
D/D |
10,000 |
11,024 |
|
- |
|
Laba Rebecque J |
VP, Corporate Operations |
|
2015-01-07 |
4 |
AS |
$17.30 |
$346,000 |
D/D |
(20,000) |
2,895 |
|
- |
|
Laba Rebecque J |
VP, Corporate Operations |
|
2015-01-07 |
4 |
OE |
$1.12 |
$22,400 |
D/D |
20,000 |
22,895 |
|
- |
|
Zsebo Krisztina M |
Chief Executive Officer |
|
2015-01-06 |
4 |
AS |
$17.51 |
$723,198 |
D/D |
(41,302) |
3,125 |
|
- |
|
Zsebo Krisztina M |
Chief Executive Officer |
|
2015-01-06 |
4 |
OE |
$1.12 |
$46,258 |
D/D |
41,302 |
44,427 |
|
- |
|
Takeya Ryan K |
VP, Manufacturing |
|
2015-01-02 |
4 |
AS |
$19.88 |
$154,607 |
D/D |
(7,777) |
1,432 |
|
- |
|
Takeya Ryan K |
VP, Manufacturing |
|
2015-01-02 |
4 |
OE |
$1.12 |
$8,710 |
D/D |
7,777 |
9,209 |
|
- |
|
Zsebo Krisztina M |
Chief Executive Officer |
|
2014-12-09 |
4 |
AS |
$15.00 |
$619,530 |
D/D |
(41,302) |
1,531 |
|
- |
|
Zsebo Krisztina M |
Chief Executive Officer |
|
2014-12-09 |
4 |
OE |
$1.12 |
$46,258 |
D/D |
41,302 |
42,833 |
|
- |
|
Rudy Jeffrey J |
VP, Clinical Operations |
|
2014-12-09 |
4 |
AS |
$15.00 |
$150,000 |
D/D |
(10,000) |
414 |
|
- |
|
Rudy Jeffrey J |
VP, Clinical Operations |
|
2014-12-09 |
4 |
OE |
$1.12 |
$11,200 |
D/D |
10,000 |
10,414 |
|
- |
|
Laba Rebecque J |
VP, Finance and Administration |
|
2014-12-05 |
4 |
AS |
$12.77 |
$255,400 |
D/D |
(20,000) |
691 |
|
- |
|
Laba Rebecque J |
VP, Finance and Administration |
|
2014-12-05 |
4 |
OE |
$1.12 |
$22,400 |
D/D |
20,000 |
20,691 |
|
- |
|
Takeya Ryan K |
VP, Manufacturing |
|
2014-12-01 |
4 |
AS |
$12.01 |
$93,402 |
D/D |
(7,777) |
577 |
|
- |
|
Takeya Ryan K |
VP, Manufacturing |
|
2014-12-01 |
4 |
OE |
$1.12 |
$8,710 |
D/D |
7,777 |
8,354 |
|
- |
|
Rudy Jeffrey J |
VP, Clinical Operations |
|
2014-11-14 |
4 |
AS |
$11.67 |
$210,060 |
D/D |
(18,000) |
0 |
|
- |
|
Rudy Jeffrey J |
VP, Clinical Operations |
|
2014-11-14 |
4 |
OE |
$1.12 |
$20,160 |
D/D |
18,000 |
18,000 |
|
- |
|
Foley Todd |
Director |
|
2014-02-04 |
4 |
B |
$8.00 |
$892,864 |
I/I |
111,608 |
1,066,775 |
2.1 |
- |
|
Foley Todd |
Director |
|
2014-02-04 |
4 |
A |
$0.00 |
$90,960 |
I/I |
955,167 |
955,167 |
|
- |
|
Wiklund Fredrik |
VP Corp Dvlpmnt & Invs Rltns |
|
2014-02-04 |
4 |
B |
$8.00 |
$160,000 |
D/D |
20,000 |
20,000 |
2.74 |
- |
|
Novartis Bioventures Ltd |
10% Owner |
|
2014-02-04 |
4 |
B |
$8.00 |
$1,299,088 |
D/D |
162,386 |
1,551,721 |
2.45 |
- |
|
Novartis Bioventures Ltd |
10% Owner |
|
2014-02-04 |
4 |
A |
$0.00 |
$132,296 |
D/D |
1,389,335 |
1,389,335 |
|
- |
|
Pfizer Inc |
10% Owner |
|
2014-02-04 |
4 |
B |
$8.00 |
$1,818,088 |
D/D |
227,261 |
1,794,803 |
2.45 |
- |
|
Pfizer Inc |
10% Owner |
|
2014-02-04 |
4 |
A |
$0.00 |
$185,160 |
D/D |
1,567,542 |
1,567,542 |
|
- |
|
161 Records found
|
|
Page 6 of 7 |
|
|